Published in Epidemiol Infect on June 12, 2012
Estimates of mumps seroprevalence may be influenced by antibody specificity and serologic method. Clin Vaccine Immunol (2013) 0.89
Underreporting of viral encephalitis and viral meningitis, Ireland, 2005-2008. Emerg Infect Dis (2013) 0.89
Susceptibility to measles, mumps, and rubella in 5-year-old children in Flanders, Belgium. Eur J Pediatr (2015) 0.86
Environmental factors potentially associated with mumps transmission in yeshivas during a mumps outbreak among highly vaccinated students: Brooklyn, New York, 2009-2010. Hum Vaccin Immunother (2013) 0.85
Characteristics of a large mumps outbreak: Clinical severity, complications and association with vaccination status of mumps outbreak cases. Hum Vaccin Immunother (2015) 0.84
Seroprevalence of antibodies against measles, rubella, mumps, varicella-zoster, and B. Pertussis in young adults of Madrid, Spain. Hum Vaccin Immunother (2013) 0.81
Outbreak-related mumps vaccine effectiveness among a cohort of children and of young adults in Germany 2011. Hum Vaccin Immunother (2013) 0.78
Viral etiology of mumps-like illnesses in suspected mumps cases reported in Catalonia, Spain. Hum Vaccin Immunother (2014) 0.78
Seroprevalence of IgG Antibodies against Mumps in Bulgarian Children under 18 Years of Age. Balkan Med J (2013) 0.75
Application of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control Programs. Vaccines (Basel) (2015) 0.75
Challenges in Interpretation of Diagnostic Test Results in a Mumps Outbreak in a Highly Vaccinated Population. Clin Vaccine Immunol (2017) 0.75
Are cases of mumps in vaccinated patients attributable to mismatches in both vaccine T-cell and B-cell epitopes?: An immunoinformatic analysis. Hum Vaccin Immunother (2013) 0.75
Mumps Virus SH protein inhibits NF-κB activation by interacting with TNFR1, IL-1R1, and TLR3 complexes. J Virol (2017) 0.75
First reported cases of human adenovirus serotype 14p1 infection, Ireland, October 2009 to July 2010. Euro Surveill (2011) 1.02